阿摩線上測驗
登入
首頁
>
台灣疼痛醫學會專科醫師
>
100年 - 100 台灣疼痛醫學會專科醫師考題#122436
> 試題詳解
16. Which drug below is less likely an option for inhibiting central sensitization following acute postoperative pain:
(A) NMDA antagonist
(B) Opioid
(C) COX2-inhibitor
(D) Pre-emptive analgesia
(E) Gabapentin
答案:
登入後查看
統計:
尚無統計資料
詳解 (共 1 筆)
MoAI - 您的AI助手
B1 · 2025/10/14
#6889953
題目解析 題目詢問的是在急性術後疼痛的情...
(共 897 字,隱藏中)
前往觀看
0
0
相關試題
6. Which drug below is less likely an option for inhibiting central sensitization following acute postoperative pain: (A) NMDA antagonist (B) Opioid (C) COX2-inhibitor (D) Pre-emptive analgesia (E) Gabapentin
#3266754
30. Which drug below is less likely an option for inhibiting central sensitization following acute postoperative pain: (A) NMDA antagonist (B) Opioid (C) COX2-inhibitor (D) Pre-emptive analgesia (E) Gabapentin
#3304702
17. Which postoperative factor may not delay recovery: (A) Pain (B) Nausea and vomiting (C) Ileus (D) Hypothermia (E) Optimal mobilization
#3305544
18. A 61-year-old woman presents to the pain clinic with a chief complaint of left shoulder and arm pain 3 years after undergoing radiation therapy for breast cancer. Physical examination reveals lymphedema of the left axilla with noticeable skin changes. Examination of the left supraclavicular area precipitates a sharp pain that radiates down her left arm. Which of the following is her likely diagnosis? (A) Tumor metastasis (B) Cervical radiculopathy (C) Reflex sympathetic dystrophy (D) Thrombangitis obliterans (E) Radiation-induced plexopathy
#3305545
19. Correct comparisons between osteoarthritis (OA) and rheumatoid arthritis (RA) dose not include: (A) Steroids and the newer drugs that focus on controlling cytokines, such as tumor necrosis factor (TNF), may reduce pain in OA and RA (B) OA mainly involve the joints and RA may present extra-articular features (C) OA appears to be a mechanically driven, and RA presents an immunologically driven disorder (D) Pain management is similar in RA and OA, but the main focus is on controlling the disease process through the use of disease-modifying antirheumatic drugs (DMARDs) (E) Female sex is a common factor in either OA or RA
#3305546
20. Which medication below is not suggested in fibromyalgia syndrome (FMS): (A) Non-steroidal anti-inflammatory drugs (ibuprofen, naproxen) (B) Pregabalin (C) Tricyclics (amitriptyline, nortriptyline, doxepin, cyclobenzaprine) (D) Opioids (E) All of the above treatments are suggested for pain management of OA
#3305547
21. A 27-year-old woman with a history of malignant melanoma and multiple subcutaneous metastases has been successfully managed with slowly increasing doses of MS-Contin (Morphine SR), in conjunction with doxepin and ibuprofen. She calls the pain center to complain of a new onset of increasing nausea, vomiting, and headaches, as well as poor pain control. The most appropriate immediate action would be to (A) speak with the patient by telephone and tell her to increase the MS-Contin (B) see the patient as soon as possible to determine if there is a new, treatable source of pain (C) schedule the patient for an evaluation in your office within the week (D) switch to a fentanyl patch since the patient is nauseated and may be unable to take oral analgesics (E) add ondansetron for nausea and vomiting so she is able to continue to take oral analgesics
#3305548
22. Piriformis syndrome 是由於梨狀肌(piriform muscle)壓迫那一條神經所導致? (A) 股神經 (femoral nerve) (B) 坐骨神經 (sciatic nerve) (C) 股外側皮神經 (lateral femoral cutaneous nerve) (D) 腓總神經 (common peroneal nerve)
#3305549
23. 根據 American College of Rheumatology 的定義,在其挑定全身的 18 處解剖區域中若有幾 處痛點即可診斷為 Fibromyalgia Syndrome: (A) 7 (B) 9 (C) 11 (D) 13 (E) 15
#3305550
24. 下列何者不具有 Na channel blocker 的作用: (A) Amitriptyline (B) Carbamazepine (Tegretol) (C) Lidocaine (D) Gabapentin (Neurontin) (E) Mexiletine (Mexitil)
#3305551
相關試卷
112年 - 112 台灣疼痛醫學會專科醫師考題#116972
2023 年 · #116972
111年 - 111 台灣疼痛醫學會專科醫師考題#116969
2022 年 · #116969
110年 - 110 台灣疼痛醫學會專科醫師考題 #120829
2021 年 · #120829
109年 - 109 台灣疼痛醫學會專科醫師考題#120915
2020 年 · #120915
108年 - 108 台灣疼痛醫學會專科醫師考題#122407
2019 年 · #122407
107年 - 台灣疼痛醫學會專科醫師考題#122426
2018 年 · #122426
106年 - 106 台灣疼痛醫學會專科醫師考題#122412
2017 年 · #122412
105年 - 105 台灣疼痛醫學會專科醫師考題#122415
2016 年 · #122415
104年 - 104 台灣疼痛醫學會專科醫師考題#122433
2015 年 · #122433
103年 - 103 台灣疼痛醫學會專科醫師考題#125057
2014 年 · #125057